July 28th: Sequencing of Molecular Testing and Treatments, with Drs. Hensing, Jackman, and West

GRACE is please to present a webinar including a series of case-based discussions that highlights the current evidence and still open questions around the optimal timing and selection of requesting certain key molecular tests in advanced NSCLC, and how we might best sequence treatments for advanced NSCLC to maximize both patient survival and quality of life.  Host Dr. Jack West will be joined by Drs. Thomas Hensing from the Northshore University Health System affiliated with the University of Chicago, and David Jackman from Dana Farber Cancer Institute in Boston. 

This program is sponsored by an educational grant from OSI Pharmaceuticals.

Registration is free, but it's limited, so if you'd like to join, please click on the link below to register.

Webinar Details:

Date: July 28th, 2010

Time: 8 PM EDT/5 PM PDT

Title: "Sequencing of Molecular Testing and Treatments"

Host:       Dr. Howard (Jack) West, Medical Oncologist, Swedish Cancer Institute, Seattle, WA

Guests:   Dr. Thomas Hensing, Medical Oncologist, Northshore Health System/Univ. of Chicago, Chicago, IL

                 Dr. David Jackman, Medical Oncologist, Dana Farber Cancer Institute, Boston, MA